medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 1

<< Back Next >>

Med Int Mex 2020; 36 (1)

Transfusion related acute lung injury

Juárez-Villa JD, Sáenz-Luna CE, Alberti-Minutti P, López-Soto V, Mejía-Sánchez SA

Language: Spanish
References: 31
Page: 94-100
PDF size: 241.49 Kb.


ABSTRACT

Background: Transfusion related acute lung injury is a rare complication associated with transfusions. It is an inflammatory process linked to the recruitment and activation of neutrophils in the lung, resulting in acute lung injury often confused with overload or pneumonia. The incidence worldwide is reported close to 0.08%; however, in Mexico there are no records. There is no specific treatment for transfusion related acute lung injury, the therapeutic measures are hemodynamic and respiratory support with oxygen and mechanical ventilation.
Clinical case: A male patient with an atypical evolution of acute pulmonary injury following ten hours of transfusion with fresh frozen plasma.
Conclusion: Transfusion related acute lung injury is a little frequent complication; its diagnosis requires high clinical suspicion and to discard affections that can be manifested with sudden dyspnea.


REFERENCES

  1. Cherry T, Stecuik M, Vishnu V, et al. Transfusion-related acute lung injury, past present and future. Am J Clin Pathol 2008;129(2):287-97. doi: 10.1309/D3F7BXH466AE3G0P.

  2. Kapur R, Kim M, Rebetz J, et al. Low levels of interleukin-10 in patients with transfusion-related acute lung injury. Ann Transl Med 2017:5(16):339-42.

  3. Vlaar A, Juffermans N. Transfusion-related acute lung injury: a clinical review. Lancet 2013;382(9896):984-94. doi: 10.1016/S0140-6736(12)62197-7.

  4. Lanman JT, Bierman HR, Byron RL Jr. Transfusion of leukemic leukocytes in man: hematologic and physiologic changes. Blood 1950;5(12):1099-1113.

  5. Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983;128(1):185- 9. DOI: 10.1164/arrd.1983.128.1.185.

  6. Fatalities Reported to FDA Following Blood Collection and Transfusions: Annual Summary for Fiscal Year 2015. Washington, DC: US Department of Health and Human Services, Office of the Assistant Secretary of Health, 2016.

  7. Kim J, Na S. Transfusion-related acute lung injury; clinical perspectives. Korean J Anesthesiol 2015;68(2):101-5. http://dx.doi.org/10.4097/kjae.2015.68.2.101.

  8. Mejía A. Riesgo transfusional del uso de plasma femenino/ masculino. Análisis y debate. Gac Med Mex 2013;149(1):89-93.

  9. Rojas C. Lesión pumonar aguda relacionada con transfusión sanguínea. Anestesia en Trauma 2016;30(supp 1):S48-S52.

  10. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119(7):1757- 67. doi: 10.1182/blood-2011-08-370932.

  11. Vlaar A, Hofstra J, Determann R. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood 2011;117(16):4218-25. doi: 10.1182/blood-2010-10-313973.

  12. Middelburg RA, van Stein D, Briet E, et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008;48(10): 2167-76. doi: 10.1111/j.1537-2995.2008.01810.x.

  13. Silliman CC, Fung Y, Ball B, Khan S. Transfusion-related acute lung injury (TRALI): current concepts and misconception. Blood Rev 2009;23(6):245-55. doi:10.1016/j. blre.2009.07.005.

  14. Triulzi D. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009;108(3):770-6. doi: 10.1213/ane.0b013e31819029b2.

  15. Rebetz J, Semple J, Kapur R. The pathogenic involvement of neutrophils in acute respiratory distress syndrome and transfusion-related acute lung injury. Transfus Med Hemother 2018;45(5):290-8. doi: 10.1159/000492950.

  16. Semple JW, Rebetz J, Kapur R. Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood 2019;133(17):1840-53. doi: 10.1182/ blood-2018-10-860809.

  17. Bux J, Sachs U. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007;136(6):788- 99. DOI: 10.1111/j.1365-2141.2007.06492.x.

  18. Otrock Z, Liu C, Grossman. Transfusion-related acute lung injury risk mitigation: an update. Vox Sang 2017;112(8):694-703. doi: 10.1111/vox.12573.

  19. Bulmberg N. The mystery of transfusion-related acute lung injury (TRALI). Transfusion 2011;51(10):2054-7. doi:10.1111/j.1537-2995.2011.03275.x.

  20. Peak D, Davis W, Walton S. Late presentation of transfusionrelated acute lung injury in the emergency department. Clin Pract Cases Emerg Med 2019;3(1):33-5. DOI: 10.5811/ cpcem.2018.11.40592.

  21. Carrillo ER, Leal GD, Carrillo Cl, et al. Lesión pulmonar aguda secundaria a transfusión. Reporte de un caso y revisión de la bibliografía. Med Int Mex 2009;25(2):154-62.

  22. Rodríguez H. Insuficiencia respiratoria pulmonar aguda y transfusión. Rev Med Inst Mex Seguro Soc 2011; 49(3): 273-80.

  23. Vlaar A, Toy P, Fung M, et al. An update of the transfusionrelated acute lung injury (TRALI) definition. Transfus Clin Biol 2019. pii: S1246-7820(19)30067-9. doi: 10.1016/j. tracli.2019.05.007.

  24. Vlaar A , Toy P, Fung M, Looney MR, Juffermans NP, Bux J, Bolton-Maggs P, Peters AL, Silliman CC, Kor DJ, Kleinman S. A consensus redefinition of transfusion-related acute lung injury. Transfusion 2019;59(7):2465-76. doi: 10.1111/trf.15311.

  25. Aubron C, Aries P, Le Niger C, Sparrow RL, Ozier Y. How clinicians can minimize transfusion-related adverse events? Transfus Clin Biol. 2018;25(4):257-61. doi: 10.1016/j. tracli.2018.08.158.

  26. Harm SK, Dunbar NM. Immunologic risks of whole blood: ABO compatibility, D alloinmunization, and transfusionrelated acute lung injury. Transfusion 2019; 59:1507-11. doi: 10.1111/trf.15168.

  27. Kuldanek S, Kelher M, Silliman C. Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update. Expert Rev Hematol 2019;12(9):773-85. doi: 10.1080/17474086.2019.1640599.

  28. Peters A, van de Weerdt E, Prinzse F. Donor characteristics do not influence transfusion-related acute lung injury incidence in a secondary analysis of two case-control studies. Transfus Clin Biol 2019;26(1):10-7. doi: 10.1016/j. tracli.2018.05.003.

  29. Kapur R, Kasetty G, Rebetz J, et al. Osteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulation. Blood 2019;134(1):74-84. doi: 10.1182/blood.2019000972.

  30. Mdawar M, Maitre B, Magnenat S. The ATP-gated P2X1 ion channel contributes to the severity of antibody-mediated Transfusion-Related Acute Lung Injury in mice. Sci Rep 2019;9(1):5159. doi: 10.1038/s41598-019-41742-9.

  31. Vossoughi S, Gorlin J, Kessler D. Ten years of TRALI mitigation: measuring our progress. Transfusion 2019;59(8):2567- 74. doi: 10.1111/trf.15387.




2020     |     www.medigraphic.com